153 related articles for article (PubMed ID: 22570759)
1. Regression of Advanced Gastric MALT Lymphoma after the Eradication of Helicobacter pylori.
Park SK; Jung HY; Kim DH; Kim MY; Lee JH; Choi KS; Choi KD; Song HJ; Lee GH; Kim H
Gut Liver; 2012 Apr; 6(2):270-4. PubMed ID: 22570759
[TBL] [Abstract][Full Text] [Related]
2. Eradication therapy is effective for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma.
Asano N; Iijima K; Terai S; Jin X; Ara N; Chiba T; Fushiya J; Koike T; Imatani A; Shimosegawa T
Tohoku J Exp Med; 2012 Nov; 228(3):223-7. PubMed ID: 23076291
[TBL] [Abstract][Full Text] [Related]
3. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
4. Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.
Morgner A; Bayerdörffer E; Neubauer A; Stolte M
Gastroenterol Clin North Am; 2000 Sep; 29(3):593-607. PubMed ID: 11030075
[TBL] [Abstract][Full Text] [Related]
5. The value of EUS in predicting the response of gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication.
El-Zahabi LM; Jamali FR; El-Hajj II; Naja M; Salem Z; Shamseddine A; El-Saghir NS; Zaatari G; Geara F; Soweid AM
Gastrointest Endosc; 2007 Jan; 65(1):89-96. PubMed ID: 17185085
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
Urakami Y; Sano T; Begum S; Endo H; Kawamata H; Oki Y
J Gastroenterol Hepatol; 2000 Oct; 15(10):1113-9. PubMed ID: 11106089
[TBL] [Abstract][Full Text] [Related]
7. Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Grgov S; Katić V; Krstić M; Nagorni A; Radovanović-Dinić B; Tasić T
Vojnosanit Pregl; 2015 May; 72(5):431-6. PubMed ID: 26165051
[TBL] [Abstract][Full Text] [Related]
8. Gastric MALT-lymphoma, gastrin and cyclooxygenases.
Konturek PC; Konturek SJ; Pierzchalski P; Starzyńska T; Marlicz K; Hartwich A; Zuchowicz M; Darasz Z; Papiez D; Hahn EG
Acta Gastroenterol Belg; 2002; 65(1):17-23. PubMed ID: 12014312
[TBL] [Abstract][Full Text] [Related]
9. Management of Suspicious Mucosa-Associated Lymphoid Tissue Lymphoma in Gastric Biopsy Specimens Obtained during Screening Endoscopy.
Yang HJ; Lim SH; Lee C; Choi JM; Yang JI; Chung SJ; Choi SH; Im JP; Kim SG; Kim JS
J Korean Med Sci; 2016 Jul; 31(7):1075-81. PubMed ID: 27366005
[TBL] [Abstract][Full Text] [Related]
10. Regression of EI2-stage low-grade gastric MALT-lymphoma after H. pylori eradication.
Cammarota G; Fedeli P; Bianchi A; Cianci R; Martino A; Fedeli G; Gasbarrini G
Hepatogastroenterology; 2005; 52(63):975-7. PubMed ID: 15966244
[TBL] [Abstract][Full Text] [Related]
11. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
Montalban C; Santon A; Boixeda D; Bellas C
Gut; 2001 Oct; 49(4):584-7. PubMed ID: 11559658
[TBL] [Abstract][Full Text] [Related]
12. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
13. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
Sackmann M; Morgner A; Rudolph B; Neubauer A; Thiede C; Schulz H; Kraemer W; Boersch G; Rohde P; Seifert E; Stolte M; Bayerdoerffer E
Gastroenterology; 1997 Oct; 113(4):1087-90. PubMed ID: 9322502
[TBL] [Abstract][Full Text] [Related]
14. The role of abdominal CT scan as follow-up after complete remission with successful Helicobacter pylori eradication in patients with H. pylori-positive stage I(E1) gastric MALT lymphoma.
Choi JY; Lee GH; Ahn JY; Kim MY; Lee JH; Choi KS; Kim DH; Choi KD; Song HJ; Jung HY; Kim JH
Helicobacter; 2011 Feb; 16(1):36-41. PubMed ID: 21241410
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
Hiyama T; Haruma K; Kitadai Y; Ito M; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Sumii K; Shimamoto F; Chayama K
Int J Oncol; 2001 Jun; 18(6):1207-12. PubMed ID: 11351252
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori.
Nakamura S; Matsumoto T; Suekane H; Takeshita M; Hizawa K; Kawasaki M; Yao T; Tsuneyoshi M; Iida M; Fujishima M
Gut; 2001 Apr; 48(4):454-60. PubMed ID: 11247887
[TBL] [Abstract][Full Text] [Related]
17. HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma.
Kawahara Y; Mizuno M; Yoshino T; Yokota K; Oguma K; Okada H; Fujiki S; Shiratori Y
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):865-8. PubMed ID: 16234023
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of gastric MALT lymphoma].
Choi MK; Kim GH
Korean J Gastroenterol; 2011 May; 57(5):272-80. PubMed ID: 21623135
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathologic study of gastric mucosa-associated lymphoid tissue lymphoma.
Ohashi S; Segawa K; Okamura S; Urano H; Kanamori S; Ishikawa H; Hara K; Hukutomi A; Shirai K; Maeda M
Cancer; 2000 May; 88(10):2210-9. PubMed ID: 10820341
[TBL] [Abstract][Full Text] [Related]
20. Is narrow-band imaging useful for histological evaluation of gastric mucosa-associated lymphoid tissue lymphoma after treatment?
Nonaka K; Ohata K; Matsuhashi N; Shimizu M; Arai S; Hiejima Y; Kita H
Dig Endosc; 2014 May; 26(3):358-64. PubMed ID: 24118642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
